These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15489495)

  • 1. Autologous serum eye drops for ocular surface disorders.
    Geerling G; Maclennan S; Hartwig D
    Br J Ophthalmol; 2004 Nov; 88(11):1467-74. PubMed ID: 15489495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous serum eye drops for the treatment of dry eye diseases.
    Kojima T; Higuchi A; Goto E; Matsumoto Y; Dogru M; Tsubota K
    Cornea; 2008 Sep; 27 Suppl 1():S25-30. PubMed ID: 18813071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous serum for ocular surface diseases.
    Quinto GG; Campos M; Behrens A
    Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye.
    Versura P; Profazio V; Buzzi M; Stancari A; Arpinati M; Malavolta N; Campos EC
    Cornea; 2013 Apr; 32(4):412-8. PubMed ID: 22955120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye.
    Phasukkijwatana N; Lertrit P; Liammongkolkul S; Prabhasawat P
    Curr Eye Res; 2011 Sep; 36(9):775-81. PubMed ID: 21851164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of autologous serum eye drops with different diluents.
    Cho YK; Huang W; Kim GY; Lim BS
    Curr Eye Res; 2013 Jan; 38(1):9-17. PubMed ID: 22928476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of serum eye drops after storage of 6 months.
    Fischer KR; Opitz A; Böeck M; Geerling G
    Cornea; 2012 Nov; 31(11):1313-8. PubMed ID: 22955119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome.
    Yoon KC; Im SK; Park YG; Jung YD; Yang SY; Choi J
    Cornea; 2006 Apr; 25(3):268-72. PubMed ID: 16633024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous serum eye drops for the treatment of persistent corneal epithelial defects.
    Arain MA; Dar AJ; Adeeb L
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):737-9. PubMed ID: 24112261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study.
    Troiano P; Monaco G
    Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous serum eye drops for the treatment of ocular surface disease.
    Azari AA; Rapuano CJ
    Eye Contact Lens; 2015 May; 41(3):133-40. PubMed ID: 25603439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy.
    Harritshøj LH; Nielsen C; Ullum H; Hansen MB; Julian HO
    Acta Ophthalmol; 2014 Dec; 92(8):783-6. PubMed ID: 24629028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis.
    Chen W; Zhang X; Liu M; Zhang J; Ye Y; Lin Y; Luyckx J; Qu J
    Exp Eye Res; 2009 Sep; 89(3):311-8. PubMed ID: 19345212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease.
    Hussain M; Shtein RM; Sugar A; Soong HK; Woodward MA; DeLoss K; Mian SI
    Cornea; 2014 Dec; 33(12):1245-51. PubMed ID: 25299423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous eye drops for the treatment of dry eye and neurotrophic keratitis.
    Mixon W; Angelle PP; Chang RI
    Int J Pharm Compd; 2009; 11(6):506-15. PubMed ID: 23965323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important concepts for treating ocular surface and tear disorders.
    Tseng SC; Tsubota K
    Am J Ophthalmol; 1997 Dec; 124(6):825-35. PubMed ID: 9402829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects?
    Hartwig D; Harloff S; Liu L; Schlenke P; Wedel T; Geerling G
    Transfusion; 2004 Dec; 44(12):1724-31. PubMed ID: 15584987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.